Covid-19 vaccine: FDA could consider authorization before Phase 3 trials are over, Financial Times reports - 2020-08-30

From UmbraXenu
Jump to: navigation, search
F203.png Covid-19 vaccine: FDA could consider authorization before Phase 3 trials are over, Financial Times reports August 30, 2020, Jamie Gumbrecht, CNN

(CNN) In an interview with the Financial Times, US Food and Drug Administration Commissioner Dr. Stephen Hahn said the agency could consider emergency use authorization or approval for a Covid-19 vaccine before Phase 3 trials are complete.

"It is up to the sponsor [vaccine developer] to apply for authorisation or approval, and we make an adjudication of their application," Hahn told the Financial Times . "If they do that before the end of Phase Three, we may find that appropriate. We may find that inappropriate, we will make a determination."

Hahn noted that an EUA is not the same as FDA approval.

Wikipedia cite:
{{cite news | first = Jamie | last = Gumbrecht | title = Covid-19 vaccine: FDA could consider authorization before Phase 3 trials are over, Financial Times reports | url = https://www.cnn.com/2020/08/30/health/fda-covid-19-vaccine-eua/index.html | work = CNN | date = August 30, 2020 | accessdate = August 31, 2020 }}